BIOCIDAL SOLAR CELL
20200221693 ยท 2020-07-16
Inventors
Cpc classification
D06M13/184
TEXTILES; PAPER
D01F11/06
TEXTILES; PAPER
D06M2400/01
TEXTILES; PAPER
C09D5/14
CHEMISTRY; METALLURGY
A01N25/34
HUMAN NECESSITIES
D01F6/34
TEXTILES; PAPER
A01N25/34
HUMAN NECESSITIES
A01N37/42
HUMAN NECESSITIES
A01N37/40
HUMAN NECESSITIES
D06M16/00
TEXTILES; PAPER
A01N37/40
HUMAN NECESSITIES
A01N37/42
HUMAN NECESSITIES
International classification
A01N25/34
HUMAN NECESSITIES
C09D5/14
CHEMISTRY; METALLURGY
D06M13/184
TEXTILES; PAPER
Abstract
This invention provides antibacterial and antiviral compositions and methods. The compositions possess prolonged and powerful antibacterial/antiviral functions under light exposure and even under completely dark conditions, while daylight exposures could recharge the functions repeatedly. In some embodiments, compositions of the invention can be employed in personal protective equipment (PPE) such as face masks, biologically self-cleaning air and water filters, medical devices, and products. The biocidal PPE can prevent transmission of infectious diseases such as Ebola and respiratory viruses. In some embodiments, compositions of the invention can be employed in food protectant materials to provide antimicrobial and antiviral bio-protection during food transportation and storage.
Claims
1. A photobiocidal polymer comprising: a foundation polymer; and a photosensitizer or photosensitizer moiety; wherein the photosensitizer or photosensitizer moiety is selected from the group consisting of a benzophenone, a quinone, and a polyphenol.
2. The photobiocidal polymer of claim 1, wherein the photosensitizer is mixed with the foundation polymer.
3. The photobiocidal polymer of claim 1, wherein the photosensitizer moiety is linked to the foundation polymer.
4. The photobiocidal polymer of claim 1, wherein the photosensitizer or photosensitizer moiety is selected from the group consisting of ##STR00017## wherein each R.sup.1 is independently selected from the group consisting of hydrogen, C.sub.1-12 alkyl, and a bond to the foundation polymer.
5. The photobiocidal polymer of claim 1, wherein the photosensitizer or photosensitizer moiety is selected from the group consisting of vitamin K3, vitamin B2, petunidin, epigallocatechin, epigallocatechin gallate, shikonin, curcurmin, ##STR00018## wherein each R.sup.1 is independently selected from the group consisting of hydrogen, C.sub.1-12 alkyl, and a bond to the foundation polymer.
6. A photobiocidal fiber comprising the photobiocidal polymer of claim 1.
7. The photobiocidal fiber of claim 6, wherein the fiber is a nanofiber.
8. The photobiocidal fiber of claim 6, wherein the fiber is a microfiber.
9. A porous membrane comprising the photobiocidal fiber of claim 6.
10. The porous membrane of claim 9, wherein the porous membrane has an average fiber diameter ranging from about 100 nm to 500 nm.
11. The porous membrane of claim 10, wherein the porous membrane has an average fiber diameter ranging from about 200 nm to 250 nm.
12. The porous membrane of claim 9, wherein the porous membrane has a thickness ranging from about 1 m to 500 m.
13. The porous membrane of claim 9, wherein the porous membrane comprises poly(vinyl alcohol-co-ethylene).
14. The porous membrane of claim 9, wherein the porous membrane comprises a biopolymer.
15. The porous membrane of claim 9, wherein the biopolymer is cellulose, alginate, chitosan, or a protein.
16. A biocidal material comprising the porous membrane of claim 9.
17. The biocidal material of claim 16, wherein the photosensitizer moiety is ##STR00019##
18. The biocidal material of claim 16, wherein the biocidal material is included in a wearable article or an article for food packaging.
19. The biocidal material of claim 16, wherein the biocidal material is attached to a surface of personal protective equipment.
20. The biocidal material of claim 16, wherein the biocidal material is included in a film or layer of a coating material.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0031]
[0032]
[0033]
[0034]
[0035]
[0036]
[0037]
[0038]
[0039]
[0040]
[0041]
[0042]
[0043]
[0044]
[0045]
[0046]
[0047]
[0048]
[0049]
[0050]
[0051]
[0052]
[0053]
[0054]
[0055]
[0056]
[0057]
[0058]
[0059]
[0060]
[0061]
[0062]
[0063]
[0064]
[0065]
[0066]
[0067]
[0068]
[0069]
[0070]
[0071]
[0072]
[0073]
[0074]
[0075]
[0076]
DETAILED DESCRIPTION OF THE INVENTION
I. Definitions
[0077] The terms a, an, or the as used herein not only includes aspects with one member, but also includes aspects with more than one member.
[0078] The term about as used herein to modify a numerical value indicates a defined range around that value. If X were the value, about X would generally indicate a value from 0.95X to 1.05X. Any reference to about X specifically indicates at least the values X, 0.95X, 0.96X, 0.97X, 0.98X, 0.99X, 1.01X, 1.02X, 1.03X, 1.04X, and 1.05X. Thus, about X is intended to teach and provide written description support for a claim limitation of, e.g., 0.98X.
[0079] When about is applied to the beginning of a numerical range, it applies to both ends of the range. Thus, from about 1 to 500 is equivalent to from about 1 to about 500. When about is applied to the first value of a set of values, it applies to all values in that set. Thus, about 7, 9, or 11% is equivalent to about 7%, about 9%, or about 11%.
[0080] In compositions comprising an additional or second component, the second component as used herein is chemically different from the other components or the first component. A third component is different from the other, first, and second components, and further enumerated or additional components are similarly different.
[0081] The terms comprise, comprises, and comprising as used herein should in general be construed as not closedthat is, as possibly including additional components that are not expressly mentioned. For example, an embodiment of a composition comprising A would include A, but might also include B, B and C, or still other components in addition to A.
[0082] The term foundation polymer as used herein refers to a polymeric material to which a photosensitizing moiety may be attached or with which a photosensitizer may be mixed. Examples of foundation polymers include polyethylene, poly(vinyl alcohol-co-ethylene),
[0083] In some embodiments, a foundation polymer is edible or ingestible by a human without adverse effects. Examples of foundation polymers that may be ingested by a human include alginate, chitosan, cellulose, poly(lactic acid), poly(glycolic acid), collagen, gelatin, and the like,
[0084] In some embodiments, a foundation polymer may include a copolymer that is modified to include a functional group providing a point of attachment for a photosensitizer moiety. An example would be the inclusion of a small amount of lactic acid monomer in a poly(glycolic acid) to provide a foundation polymer with alcohol groups on the polymer backbone.
[0085] The term or as used herein should in general be construed non-exclusively. For example, an embodiment of a composition comprising A or B would typically present an aspect with a composition including both A and B. Or should, however, be construed to exclude those aspects presented that cannot be combined without contradiction (e.g., a average thickness that is between 100 and 200 or between 400 and 500).
[0086] The term microfiber as used herein refers to a fiber with a thickness of between about 1 micrometer (m) to 1000 m (e.g., about 1 to 5; about 2 to 10; about 3 to 15; about 5 to 25; about 10 to 50; about 25 to 100; about 50 to 250; about 100 to 500). Typically, a microfiber is one of a group of polymeric fibers that have an average thickness of between about 1 m to 1000 m.
[0087] The term nanofiber as used herein refers to a fiber with a thickness of between about 1 nm to 1000 nm (e.g., about 1 to 5; about 2 to 10; about 3 to 15; about 5 to 25; about 10 to 100; about 15 to 150; about 25 to 200 or 250; about 50 to 400 or 500; about 75 to 750). Typically, a nanofiber is one of a group of polymeric fibers that have an average thickness of between about 1 nm to 1000 nm.
[0088] The term photosensitizer as used herein refers to a chemical compound that can absorb light and produce reactive oxygen species, either directly (e.g., by direct formation of hydroxy or perooxy radical species) or indirectly (e.g., by transferring the energy to another photosensitizer molecule of the same or a different structure, which then produces reactive oxygen species).
[0089] The term photosensitizer moiety or photosensitizer group as used herein refers to a photosensitizer has a point of attachment (e.g., a covalent bond or bonds) to another molecule, such as a polymer.
[0090] In some embodiments, the point of attachment is an ester or an amide group that is derived from part of the photosensitizer (e.g., an acid group) and the polymer (e.g., an alcohol or amino group on the polymer, either directly or through a spacer group, such as a polyethylene or other dihydroxy group, that is not part of the repeating unit). In some embodiments, the point of attachment is an carbonate, urea, or urethane group that is derived from part of the photosensitizer (e.g., an alcohol or amino group) and the polymer (e.g., an alcohol or amino group on the polymer) that are coupled with a phosgene equivalent, such as carbonyl diimidazole (CDI) or triphosgene.
[0091] The term reactive oxygen species or ROS as used herein refers to chemically reactive, oxygen-containing free radical species or their reactive products. Examples include peroxy, superoxy, and hydroxyl radicals as well as photochemically produced hydrogen peroxide. In some embodiments, ROS are produced by transfer of energy from a photosensitizer.
[0092] The term w/w or wt/wt means a percentage expressed in terms of the weight of the ingredient or agent over the total weight of the composition multiplied by 100.
II. Embodiments
[0093] Provided herein are materials and methods involving daylight-driven antibacterial and antiviral rechargeable micro- or nanofibrous membranes (RNMs) by incorporating daylight-active chemicals that can effectively and efficiently produce reactive oxygen species (ROS). The daylight-active chemicals can be photosensitizers with additionally incorporated structures that can enhance their photo-activities. By using this design, the inventors have surprisingly discovered that daylight-active agents and RNMs can store photo-induced biocidal activity under conditions of light irradiation, and readily release ROS providing biocidal functions under dim or dark conditions. The RNMs can exhibit integrated properties of robust daylight absorbance, fast ROS production, ease of activity storage, long-term durability, and high biocidal efficacy. The incorporation of RNMs as a biocidal surface protective layer on protective equipment can provide robust bio-protection against both bacterial and viral pathogens. The incorporation of edible RNMs as a biocidal surface protective layer on food can provide bio-protection against both bacterial and viral pathogens, leading to extended shelf life and less food waste.
[0094] In some embodiments, RNMs were prepared and selected based on three criteria: (1) effective interception of pathogen particles via the porous nanostructure of the membranes, (2) incorporation of daylight-active biocidal agents under daylight irradiation, and (3) storage of biocidal activity and ready release of the activity under dark condition. The first requirement was satisfied by using micro- or nanotextured materials such as ultrafine electrospun nanofibers as templates for achieving a breathable interception barrier. To satisfy the other two criteriatogether providing for the formation of rechargeable biocidal functionsa molecular design was used that was based on benzophenones and polyphenols. Without being bound by a particular theory, it is believed that the biocidal activity of these compounds originates from ROS generated when the compounds were exposed to light irradiation in the presence of oxygen.
[0095] In some embodiments, the present inventions sets forth a photobiocidal polymer including: [0096] a foundation polymer; and [0097] a photosensitizer or photosensitizer moiety; wherein the photosensitizer or photosensitizer moiety is selected from a benzophenone, a quinone, and a polyphenol.
[0098] In some embodiments, the photosensitizer or photosensitizer moiety is selected from a benzophenone. Benzophenone and its derivatives incorporate the photoactive group:
##STR00003##
In some embodiments, the aryl rings can have one or more substituents selected from halo (i.e., F, Cl, Br, and I), C.sub.1-12 alkyl, hydroxyl, C.sub.1-12 ether, amino, C.sub.1-12 amino, carboxylic acid, C.sub.1-12 ester, and C.sub.1-12 amide. In some embodiments, an acid anhydride ring can be fused with one or more sides of the aryl rings, as in the photosensitizer or photosensitizer moiety:
##STR00004##
wherein each R.sup.1 is independently selected from hydrogen, alkyl (e.g., C.sub.1-12 alkyl), and a bond to the foundation polymer.
[0099] In some embodiments, the photosensitizer or photosensitizer moiety is selected from a quinone, such as an anthraquinone. Anthraquinone and its derivatives incorporate the photoactive group:
##STR00005##
[0100] In some embodiments, the aryl rings can have one or more substituents selected from halo (i.e., F, Cl, Br, and I), C.sub.1-12 alkyl, hydroxyl, C.sub.1-12 ether, amino, C.sub.1-12 amino, carboxylic acid, C.sub.1-12 ester, and C.sub.1-12 amide. In some embodiments, an acid anhydride ring can be fused with one or more sides.
[0101] In some embodiments, the photosensitizer or photosensitizer moiety is selected from a polyphenol. Polyphenols incorporate at least one phenyl ring with multiple hydroxyl or ether groups, such as the photosensitizer or photosensitizer moiety:
##STR00006##
wherein each R.sup.1 is independently selected from hydrogen, alkyl (e.g., C.sub.1-12 alkyl), and a bond to the foundation polymer.
[0102] In some embodiments, the photosensitizer is mixed with the foundation polymer. In some embodiments, the photosensitizer is from about 1 to about 25% w/w of the foundation polymer (e.g., about 1 to 15%; about 5 to 15%; about 3 to about 15%; about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, or 25%).
[0103] In some embodiments, the photosensitizer moiety is linked to the foundation polymer. In some embodiments, the photosensitizer moiety is from about 1 to about 25% w/w of the foundation polymer (e.g., about 1 to 15%; about 5 to 15%; about 3 to about 15%; about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, or 25%).
[0104] In some embodiments, the photosensitizer moiety is linked directly to the foundation polymer. In some embodiments, the photosensitizer moiety is linked though a spacer group (e.g., a C.sub.2-30 alkyl diether, a poly(alkylene glycol), a C.sub.2-30 alkyl diamide, or a C.sub.2-30 alkyl diester).
[0105] In some embodiments, the photosensitizer or photosensitizer moiety is selected from the group:
##STR00007##
wherein each R.sup.1 is independently selected from hydrogen, alkyl (e.g., C.sub.1-12 alkyl), and a bond to the foundation polymer. In some embodiments, the photosensitizer or photosensitizer moiety is selected from any one, any two, any three, or any four of the generic structures shown above.
[0106] In some embodiments, the photosensitizer or photosensitizer moiety is selected from vitamin K3, vitamin B2, petunidin, epigallocatechin, epigallocatechin gallate, shikonin, curcurmin,
##STR00008##
wherein each R.sup.1 is independently selected from hydrogen, alkyl (e.g., C.sub.1-12 alkyl), and a bond to the foundation polymer. In some embodiments, the photosensitizer or photosensitizer moiety is vitamin K3. In some embodiments, the photosensitizer or photosensitizer moiety is vitamin B2. In some embodiments, the photosensitizer or photosensitizer moiety is petunidin. In some embodiments, the photosensitizer or photosensitizer moiety is epigallocatechin. In some embodiments, the photosensitizer or photosensitizer moiety is epigallocatechin gallate. In some embodiments, the photosensitizer or photosensitizer moiety is shikonin. In some embodiments, the photosensitizer or photosensitizer moiety is curcurmin.
[0107] In some embodiments, the photosensitizer or photosensitizer moiety is
##STR00009##
[0108] In some embodiments, the photosensitizer or photosensitizer moiety is
##STR00010##
[0109] In some embodiments, the invention sets forth a photobiocidal fiber including a photobiocidal polymer as otherwise disclosed herein. In some embodiments, the photobiocidal fiber is a nanofiber. In some embodiments, the photobiocidal fiber is a microfiber.
[0110] In some embodiments, the photobiocidal fiber is a microfiber. In some embodiments, the photobiocidal fiber has a thickness (or an average thickness) of about 1 to 5 m (e.g., about 1, 2, 3, 4, or 5). In some embodiments, the photobiocidal fiber has a thickness (or an average thickness) of about 2 to 10 m (e.g., about 2, 3, 4, 5, 6, 7, 8, 9, or 10). In some embodiments, the photobiocidal fiber has a thickness (or an average thickness) of about 3 to 15 m (e.g., about 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, or 15; about 5 to 25; about 10 to 50; about 255 to 100).
[0111] In some embodiments, the invention sets forth a porous membrane including a photobiocidal fiber as otherwise disclosed herein.
[0112] In some embodiments, the porous membrane has an average fiber diameter ranging from about 100 nm to 500 nm (e.g., about 200 nm to 250 nm; about 100 to 300; about 150 to 350; about 100, 110, 120, 130, 140, 150, 160, 170, 180, 190, 200, 205, 210, 215, 220, 225, 230, 235, 240, 245, 250, 260, 270, 280, 290, 300, 310, 320, 330, 340, 350, 360, 370, 380, 390, 400, 410, 420, 430, 440, 450, 460, 470, 480, 490, or 500).
[0113] In some embodiments, the porous membrane has a thickness ranging from about 1 m to 500 m (e.g., about 1 to 10, about 10 to 100, about 100 to 250, about 200 nm to 500, about 100 to 300; about 150 to 350; about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, 100, 110, 120, 130, 140, 150, 160, 170, 180, 190, 200, 205, 210, 215, 220, 225, 230, 235, 240, 245, 250, 260, 270, 280, 290, 300, 310, 320, 330, 340, 350, 360, 370, 380, 390, 400, 410, 420, 430, 440, 450, 460, 470, 480, 490, or 500).
[0114] In some embodiments, the porous membrane includes poly(vinyl alcohol-co-ethylene). In some embodiments, the porous membrane includes a biopolymer (e.g., a polysaccharide, such as cellulose, alginate, or chitosan; a protein, such as gelatin or collagen).
[0115] In some embodiments, the invention sets forth a biocidal material including a porous membrane as otherwise disclosed herein.
[0116] In some embodiments, the incorporation of RNMs as a biocidal-surface protective layer on protective equipment can provide robust bio-protection against both bacterial and viral pathogens.
[0117] In some embodiments, the invention sets forth a wearable article including [0118] a personal protective equipment, and [0119] a biocidal material as otherwise disclosed herein; [0120] wherein the biocidal material is attached to a surface of the personal protective equipment. In some embodiments, the surface is an outer or intermediate surface of the personal protective equipment.
[0121] In some embodiments, the personal protective equipment is a face mask or respirator. In some embodiments, the personal protective equipment is a bio-protective suit or laboratory coat. In some embodiments, the personal protective equipment is a glove.
[0122] In some embodiments, the incorporation of non-toxic or edible RNMs as a biocidal packaging material or a protective coating on food can provide bio-protection against both bacterial and viral pathogens, leading to extended shelf life and less food waste. In some embodiments, the invention sets forth an article for food packaging comprising a biocidal material as otherwise disclosed herein. In some embodiments, the article is a film or layer of coating material.
[0123] In some embodiments, the invention sets forth a product substantially as described herein.
[0124] In some embodiments, the invention sets forth a biocidal material comprising: [0125] a nanofibrous membrane; and [0126] a photoactive chemical selected from the group consisting of
##STR00011##
In some embodiments, the photoactive chemical is bonded to the nanofibrous membrane.
[0127] In some embodiments, the invention sets forth the biocidal material as discussed herein, wherein the photoactive chemical is
##STR00012##
[0128] In some embodiments, the invention sets forth the biocidal material as discussed herein, wherein the photoactive chemical is
##STR00013##
[0129] In some embodiments, the invention sets forth the biocidal material as discussed herein, wherein the photoactive chemical is
##STR00014##
[0130] In some embodiments, the invention sets forth the biocidal material as discussed herein, wherein the photoactive chemical is
##STR00015##
[0131] In some embodiments, the invention sets forth the biocidal material as discussed herein, wherein the nanofibrous membrane comprises poly(vinyl alcohol-co-ethylene).
[0132] In some embodiments, the invention sets forth the biocidal material as discussed herein, wherein the nanofibrous membrane has an average fiber diameter ranging from 200 nm to 250 nm.
[0133] In some embodiments, the invention sets forth the biocidal material as discussed herein, wherein the nanofibrous membrane has a thickness ranging from 1 m to 500 m.
[0134] In some embodiments, the invention sets forth a compound having the formula:
##STR00016##
[0135] In some embodiments, the invention sets forth a process substantially as hereinbefore described.
III. Examples
Example 1: Preparation of Nanofiber Networks and Membranes
[0136]
[0137] To test for a synergistic effect, the BD-RNM was further grafted with CA to obtain BDCA-RNM samples (
Example 2: Biocidal Effects of Rechargeable Nanofiber Membranes
[0138]
[0139] Without intending to limit the invention, a proposed mechanism for the photo-active and photo-storable biocidal functions is illustrated in
Example 3: Excitation Features of RNMs
[0140] To provide insight into the excitation features of the RNMs, time-dependent density functional theory (TD-DFT) calculations and diffuse reflection UV-vis spectroscopy were used to evaluate the nature of the initial photoexcitation event. From Table 1, The TD-DFT calculations of the RNMs predict that the lower energy S.sub.0.fwdarw.S.sub.1 excitations are dominantly dark with very weak oscillator strength. Meanwhile, the S.sub.0.fwdarw.S.sub.n excitations of the RNMs are predicted to be bright, and the calculated maximum wavelength (.sub.max) matched with the measured UV-vis spectra, as shown in
TABLE-US-00001 TABLE 1 Singlet excitation wavelengths and oscillator strengths (f) of the relevant RNMs by TD-DFT calculations. Excited States BA-RNM BD-RNM CA-RNM BDCA-RNM S.sub.1 347.21 nm 366.67 nm 341.471 nm 400.21 nm f = 0.0000 f = 0.0026 f = 0.3140 f = 0.002 S.sub.2 301.34 nm 334.36 nm 294.92 nm 364.15 nm f = 0.0144 f = 0.0141 f = 0.4892 f = 0.0032 S.sub.3 291.53 nm 315.47 nm 267.53 nm 334.03 nm f = 0.2697 f = 0.0089 f = 0.0001 f = 0.0001 S.sub.4 287.23 nm 307.21 nm 249.79 nm 333.92 nm f = 0.0121 f = 0.0934 f = 0.3248 f = 0.0036 S.sub.5 283.18 nm 307.03 nm 248.47 nm 325.22 nm f = 0.1489 f = 0.0451 f = 0.0006 f = 0.5306 S.sub.6 277.54 nm 304.68 nm 247.51 nm 322.77 nm f = 0.1279 f = 0.0066 f = 0.0322 f = 0.0171
[0141] After initial photon absorption, fast relaxation via internal conversion (IC) results in thermalization of the excited electron from S.sub.n to the lowest singlet excited state S.sub.1, followed by ISC to the lowest triplet excited state (T.sub.1), from wherein a series of photo-reactions can originate. Interestingly, inspection of the frontier orbitals of Ti reveals qualitative differences in these RNMs. The BA-RNM and BD-RNM possess similar n.sub.HOMO-.sub.LOMO transitions in T.sub.1, with both n electron localized on carbonyl group and it electron localized over the entire conjugate system. In contrast, the CA-RNM exhibited a typical .sub.HOMO-.sub.LOMO transition with both it and * orbitals localized on phenyl ring system. Moreover, by the combination of the benzophenone and the polyphenol, the T.sub.1 of BDCA-RNMs exhibit unique charge transfer character with an n.sub.HOMO-.sub.LUMO+3 transition, wherein an electron occupying HOMO orbital, which is an n orbital localized on the carbonyl group in benzophenone, is promoted into the spatially separated * LUMO+3 localized on the conjugated system of CA.
Example 4: ROS Photoactivity of RNMs
[0142] To test the photo-activity of some relevant RNMs, a daylight irradiation device with an irradiance of 6.5 mW cm.sup.2 was equipped with an easily available light sourcea D65 standard daylight tube (GE F15T8/D)and the formed ROS were measured in terms of two typical species: OH. and H.sub.2O.sub.2. The relevant RNMs were subjected to a cyclic irradiation test with 20 min interval light-dark fatigue cycles. As shown in
[0143] Without intending to be bound by theory, the photo-induced ROS generation cycle involves the hydrogen abstraction (RNMH./.sup.3RNM) by the triplet RNMs and a subsequent oxidation (RNM/RNMH.) by oxygen. To provide insight into the mechanism of the photo-induced reaction, DFT was used to calculate the energy of the relevant reaction moieties (Table 2). The reaction feasibility was also quantified using Gibbs free energy (AG). As shown in
[0144] These results were further supported by the electrostatic potential (ESP)-mapped electron density of the Ti and ground state of these RNMs. As shown in
TABLE-US-00002 TABLE 2 Gibbs free energy (with unit in Hartree) of the relevant reaction moieties of RNMs by DFT calculations. BDCA-RNM BDCA-RNM States BA-RNM BD-RNM CA-RNM (intra-) (inter-) RNM 765.0991 1177.9609 1297.3255 2474.5989 2475.2237 .sup.3RNM* 765.0051 1177.8690 1297.4032 2475.1422 2475.1422 RNMH 765.6704 1178.5332 1297.9338 2475.1628 2475.8023
Example 5: Rechargeable Biocidal Properties of RNMs
[0145] The properties of photoactive nanofibrous-structured RNMs can be further demonstrated by their promising rechargeable biocidal functions. Without intending to be limited by theory, the photoactive cycle consists of the excitation, hydrogen abstraction, and quenching by oxygen. However, if the generated RNMH. is not fully quenched by oxygen or other organic burdens (for example, microbial), other competing reaction related to activity storage can occur. To demonstrate this, the relevant RNMs were irradiated under daylight with increasing exposure times up to 60 minutes, and the photo-induced reaction and structure rearrangement were studied with UV-vis spectroscopy and TD-DFT calculations, as shown in
[0146] The photo-induced structural reorganization of RNMs by typical absorption intensity change related was further compared to DPM (262 nm) and LAT (440 nm) structures. As shown in
[0147] A recharging cyclic test of BDCA-RNM was also performed as indicated in the graph of
[0148] In addition, stability for long-term storage of the LAT structure is another practical concern for recharging performance. A decay of the LAT structure has a notable impact on the existence of oxygen and reductive organic matters, which could lead to a quick release of ROS. Therefore, if the RNMs were stored in a dry and closed condition, the absorption band associated with the LAT structure should exhibit slow decays, as observed in
Example 6: RNM Antibacterial Activity
[0149] To evaluate the antibacterial activity of the RNMs, the membrane surfaces were first challenged with two typical pathogenic bacteria, gram-negative Escherichia coli (E. coli) O157:H7 and gram-positive Listeria innocua (L. innocua). For the contact-killing assay, control (pristine PVA-co-PE nanofibrous membranes) and BDCA-RNM samples with a size of 22 cm.sup.2 were loaded with 10 L of 110.sup.8 colony forming units (CFU) of a bacterial suspension (2.510.sup.5 CFU cm.sup.2), and the bacterial proliferation was assessed by agar plate counting.
[0150] Moreover, in dramatic contrast to traditional photo-antimicrobial materials, the BDCA-RNM can store the biocidal activity and kill bacteria under dark conditions, as shown in
[0151] To gain insight into the bactericidal mechanism of the RNMs, the morphological changes of bacteria after contacts with the RNMs were investigated. As shown in
[0152] To further assess the damage induced on bacterial cell membranes, leakage of nucleic acids and proteins from the bacterial cells was detected after contacting with BDCA-RNM samples. Supernatants of pelleted culture were analyzed for spectrophotometric absorbance readings at 260 and 280 nm, corresponding to the characteristic peaks of nucleic acids and proteins, respectively. As shown in
[0153] These results indicate that the bactericidal function of the BDCA-RNMs is similar to that of peroxide disinfectants commonly used in medical disinfection in that the both involve bacterial cell wall and membrane disruption. Moreover, contact killing and free ROS release are both possible mechanisms, but the contact killing plays a dominant role for the RNMs. Because the ROS radicals possess a quite short lifetime of <10 is with negligible migration distance, stable H.sub.2O.sub.2 may not be able to reach a critical biological activity level in such a short time (<10 min). Therefore, the use of the RNMs is also advantageous in avoiding undesirable free ROS release and accumulation by utilizing ROS effectively and safely.
Example 7: RNM Antiviral Activity
[0154] Antiviral function, defined as the killing or inactivation of viruses, is another desired property for bio-protective PPE materials. To evaluate the antiviral performance of the RNMs, the membrane surface was tested with T7 bacteriophage and the viral activity was evaluated by E. coli based stationary-phase plating assay. T7 phage is a non-enveloped dsDNA virus that has a single proteinaceous capsid which has been shown to be less sensitive to photodynamic destruction than that of enveloped or RNA-based viruses. Therefore, T7 phage is an appropriate viral model to test the reduction of viruses by contact with the RNMs. As shown in
Example 8: Applicability of BDCA-RNM for PPE Applications
[0155] To demonstrate the applicability of BDCA-RNM as a biocidal surface function layer for bio-protection applications using current PPE materials, the interception properties of the BDCA-RNM against ultrafine particles were investigated. Filtration performance evaluations were carried out with the use of polydisperse sodium chloride (NaCl) particles with diameter of 300-500 nm under increasing airflow. As shown in
[0156] As a proof-of-concept for bio-protective PPE application, the charged BDCA-RNM (1 hour of daylight irradiation) was attached to a conventional respirator and protective suit. As shown in
Example 9: Materials and Methods for Examples
[0157] Poly(vinyl alcohol-co-ethylene) (PVA-co-PE, ethylene content of 27 mol %), 4-benzoylbenzoic acid, 3,3,4,4-benzophenone tetracarboxylic dianhydride (BPTCD), tetrahydrofuran (THF), dioxane, acetone, chloroform, isopropanol, polyphosphoric acid (PPA), 25 wt % glutaraldehyde solution, 37% formaldehyde solution, and 4 wt % osmium tetroxide (OsO4), potassium iodide, sodium hydroxide, ammonium molybdate tetrahydrate, potassium hydrogen phthalate, propidium iodide (PI), and Sybr green (SG) dye were purchased from Sigma-Aldrich (Milwaukee, Wis., USA). p-nitrosodimethylaniline (p-NDA), chlorogenic acid, Luria-Bertani (LB) broth, LB agar, Tryptic soy broth (TSB), and Tryptic soy agar (TSA) were purchased from Fisher Scientific (Hampton, N.H., USA). Phosphate buffer saline (PBS) and Tris-buffered saline (TBS) were obtained from USB Co. Ltd. (Cleveland, Ohio, USA).
[0158] The electrospinning solution was prepared by dissolving PVA-co-PE (M.sub.n=90,000, Sigma-Aldrich) in a mixture of isopropanol and water (weight ratio of 7:3) at 80 C. with stirring for 6 h, the concentrations of PVA-co-PE was 7 wt %. Afterward, the solution was transferred to a 20 mL syringe capped with a 6-G needle and fed with a controllable rate of 2 mL h.sup.1 using a programmable syringe pump (Kent Scientific). A high voltage of 30 kV (EQ30, Matsusada Inc.) was applied to the needle tip, resulting in a generation of a continuous jetting stream. The resulting PVA-co-PE nanofibrous membranes were deposited on a wax-paper covered metallic roller at a 20 cm tip-to-collector distance, and then dried in vacuum at 50 C. for 2 h to remove any residual solvent. .sup.1H NMR (400 MHz, DMSO-d.sub.6): (ppm)=1.27 (d, 4H), 3.01-4.79 (m, 1H)
[0159] In the case of BA-RNM, 0.2 g of 4-benzoylbenzoic acid and 5 g of CDI were dissolved in 20 mL of THF, then 0.1 g of PVA-co-PE nanofibrous membranes were immersed into the as-prepared solution with stirring at 60 C. After 2 h of reaction, the resulted membranes were washed with acetone and dried in vacuum. .sup.1H NMR (400 MHz, DMSO-d.sub.6): (ppm)=1.27 (d, 4H), 2.92-5.01 (m, 1H), 7.03-8.48 (m, 9H).
[0160] In the case of CA-RNM, 0.2 g of chlorogenic acid and 5 g of CDI were dissolved in 20 mL of THF, then 0.1 g of PVA-co-PE nanofibrous membranes were immersed into the as-prepared solution with stirring at 60 C. After 2 h of reaction, the resulted membranes were washed with acetone and dried in vacuum. .sup.1H NMR (400 MHz, DMSO-d.sub.6): (ppm)=1.27 (d, 4H), 1.64-1.88 (m, 2H), 1.88-2.10 (m, 2H) 3.16-4.78 (m, 4H), 5.21 (d, 1H), 6.15 (d, 1H), 6.63-7.51 (m, 3H).
[0161] In the case of BD-RNM, 0.2 g of BPTCD and 0.2 g of PPA were dissolved in 20 mL of dioxane, then 0.1 g of PVA-co-PE nanofibrous membranes were immersed into the as-prepared solution with stirring at 80 C. After 2 h of reaction, the resulted membranes were washed with acetone and dried in vacuum. .sup.1H NMR (400 MHz, DMSO-d.sub.6): (ppm)=1.27 (d, 4H), 2.88-4.79 (m, 1H), 7.73-8.32 (m, 6H).
[0162] In the case of BDCA-RNM, 0.2 g of chlorogenic acid and 0.2 g of PPA were dissolved in 20 mL of dioxane, then 0.1 g of above BD-RNM was immersed into the as-prepared solution with stirring at 80 C. After 2 h of reaction, the resulted membranes were washed with acetone and dried in vacuum. .sup.1H NMR (400 MHz, DMSO-d.sub.6): (ppm)=1.27 (d, 4H), 1.64-1.84 (m, 2H), 1.86-2.15 (m, 2H), 2.88-4.82 (m, 4H), 5.21 (d, 1H), 6.15 (d, 1H), 6.59-8.50 (m, 9H).
[0163] A daylight irradiation device (Spectrolinker XL-1500, Spectronics Corporation, NY, USA) equipped with a D65 standard light source (GE F15T8/D) was used in our experiment. The output power was set to be an irradiance of 6.5 mW cm.sup.2 at a distance of 16 cm from the lamp. The generation of ROS was measured in terms of the amounts of OH. and H.sub.2O.sub.2. The yield of OH* was quantified by the bleaching of p-NDA, which was a selective scavenger for quenching hydroxyl radicals. In a typical experiment, 10 mg of the sample membranes were immersed into 10 mL of p-NDA (50 mol L.sup.1), which was exposed under daylight or dark conditions for a certain time. The amount of p-NDA left in the solution was measured quantitatively with the absorbance at .sub.max with 440 nm. Similarly, the amount of H.sub.2O.sub.2 was quantified with an indirect spectrophotometric method. In a typical test, 10 mg of the sample membranes were placed in 10 mL of deionized water, which was exposed under daylight or dark conditions for a certain time. After the exposure, 1 mL of sample solution was mixed with 1 mL of a reagent I (aqueous solution of potassium iodide, 66 g L.sup.1, sodium hydroxide, 2 g L.sup.1, and ammonium molybdate tetrahydrate, 0.2 g L.sup.1) and 1 mL of a reagent II (aqueous solution of potassium hydrogen phthalate, 20 g L.sup.1) with stirring for 5 min. The concentration of formed H.sub.2O.sub.2 in the solution was measured quantitatively with the absorbance at .sub.max with 351 nm.
[0164] Bactericidal experiments were performed on the typical etiological bacteria, gram-negative E. coli O157:H7 (ATCC 700728, Manassas Va., USA) and gram-positive L. innocua (ATCC 33090, Manassas, Va., USA). 10 mL of LB broth was inoculated with a colony of E. coli 0157 and grown at 37 C. at 150 rpm. A bacterial culture with an absorbance at 600 nm of 0.4 (210.sup.8 CFU mL.sup.1 assessed by plate counting) was used for the further experiments. Similarly, a colony of L. innocua was grown in 10 mL of TSA broth at 30 C. at 150 rpm until it reached an absorbance at 600 nm of 1.5 (110.sup.9 CFU mL.sup.1 assessed by plate count) and used for the following experiments.
[0165] T7 bacteriophage (ATCC, BAA-1025-B2, Manassas, Va., USA) was cultured in E. coli BL21 cells (ATCC # BAA-1025) in 10 mL of LB medium, and allowed to incubate at 37 C. with a shaking speed of 250 rpm. After 4 h incubation, 2.5 ml of chloroform was added to the solution, and allowed to incubate at 37 C. for 20 min with moderate shaking to lyse any remaining bacteria. Then the culture was centrifuged for 10 min at 5800 rpm to remove bacterial debris. The supernatant containing the phages was decanted and chilled on ice overnight at 4 C. prior to centrifugation at 11,000 rpm for 15 min. The pellet was suspended in sterile water and diluted in PBS until a titer of 1.010.sup.7 plaque-forming units (PFU) per milliliter was obtained (confirmed by plaque count plating).
[0166] In a typical experiment, 10 L of the bacterial (E. coli or L. innocua) suspension were spotted on the surface of control samples (PVA-co-PE) or RNM samples in a size of 22 cm.sup.2, then the samples were exposed to daylight or dark conditions for a certain time. At each time point, the samples with the bacteria were vortexed in a tube containing 1 mL of DI water, and the suspension was serially diluted (10.sup.1, 10.sup.2, 10.sup.4, and 10.sup.6) to be plated on LB agar (E. coli) or TSA agar (L. innocua) for the bacterial enumeration. For the cyclic antimicrobial assays, after each test the samples were sonicated for 5 min to remove the attached bacterial debris.
[0167] The bacteria loaded on the control or RNM samples were harvested by vortexing the samples in a tube containing 500 L of DI water, and washed 3 times with PBS. In the case of fluorescence microscope imaging, the bacterial suspension was added with 5 g mL.sup.1 of PI and SG fluorescence) DNA dye (10,000 times dilution, and incubated in dark for 20 min at room temperature. Then, 10 L of the suspension was spotted on a microscope slide and visualized using a laser scanning confocal microscope (Olympus FV1000). In the case of SEM imaging, the bacterial suspension was fixed in PBS solution containing 2 wt % of formaldehyde and 1 wt % of glutaraldehyde for 1 h, then the bacteria were rinsed with DI water three times followed by soaking in 1% OsO4 solution for 30 min. Bacterial samples were then dehydrated by a sequential 10 min immersion/removal of ethanol/water mixtures with an increasing ethanol content of 25, 50, 75, 90, and 100%, respectively. Finally, the bacterial samples were placed on copper tape and coated with palladium prior to SEM analysis.
[0168] In a typical experiment, 10 L of the phage dilution were spotted on the surface of control or RNM samples in a size of 22 cm.sup.2; then the samples were exposed to daylight or dark conditions for a certain time. At each time point, the samples with the phages were vortexed in a tube containing 2 mL of Tris-buffered saline. After serial dilution, 0.1 mL of phage solution was mixed with 0.25 mL of stationary-phase host E. coli BL21 (approximately A600 nm=1.5 OD), followed by incubation for 10 min at 37 C. Afterwards, 3 mL of molten LB agar at 45 C. was added and mixed with the incubated bacteria plus phages and immediately poured onto a pre-warmed LB agar plate and allowed to solidify. Once the plate solidified, all the plates were inverted and incubated at room temperature overnight, and then the plaques were counted. Phage was counted and reported as PFU mL.sup.1.
[0169] All calculations were performed using computational chemistry software package Gaussian 09 ver. 08. Initial geometries at ground state were optimized at computed at unrestricted DFT-B3LYP/6-31+G(d,p) level of theory in CPCM-H.sub.2O solvent. Using these geometries, the nature of singlet and triplet excited states and transition energies calculations were performed using the TDDFT-B3LYP/6-31+G(d,p) level of theory in CPCM-H.sub.2O solvent. The Gibbs free energies of all compounds were obtained by frequency calculations at unrestricted DFT-B3LYP/6-311+G(d,p) level of theory in CPCM-H.sub.2O solvent using geometries optimized at unrestricted DFT-B3LYP/6-31+G(d,p) level of theory in CPCM-H.sub.2O solvent. The electrostatic potential (ESP) calculation was performed by single point energy calculations with CHELPG5 ESP population analysis at unrestricted DFT-B3LYP/6-31+G(d,p) level of theory in CPCM-H.sub.2O solvent. Total electron density was first plotted and then were mapped with ESP derived charges to show a distribution of charges on the molecular structure.
[0170] Field emission scanning electron microscopy (FE-SEM) images were examined by a Philips FEI XL30. UV-vis absorption spectra were collected with an Evolution 600 spectrophotometer (Thermo Scientific, USA), the diffuse reflection spectra were collected with a DRA-EV-600 diffuse reflectance accessory (Labsphere, USA). .sup.1H NMR spectra were recorded on a 400 MHz Bruker Avance HD spectrometer and d.sub.6-DMSO was used as a solvent. A TSI Model 8130 automated filter tester (TSI, Inc., MN, USA) was used to measure the filtration efficiency and pressure drop, NaCl monodisperse aerosols with a size of 0.3-0.5 m and a standard deviation less than 1.86 were used as the model particles.
Example 10: Applicability of RNM for Food Protection
[0171] Vitamin K3 (VK3) was physically blended with poly vinyl alcohol-co-poly ethylene (PVA-co-PE), a commonly used food packaging material, and fabricated into photoactive nanofibrous membrane via electrospinning technique.
[0172] The electrospinning solution was prepared by dissolving PVA-co-PE (Mn=90,000; Sigma-Aldrich) polymer particles in a mixture of water and isopropanol (weight ratio of 3:7) at 85 C. with stirring for 4 hours; the concentration of PVA-co-PE was 8 wt %. Then VK3 (10 wt % of PVA-co-PE) was added to this solution and mixed well. Afterward, the solution was transferred to a 20-ml syringe capped with needle (1.27 mm2.5 cm). A syringe pump (New Era Pump Systems, Inc.) was used to feed the solution with a rate of 2 ml hour.sup.1. A high voltage of 28 kV (DW-03, E-star Group Technology Co., Ltd) was applied to the needle generating a continuous charged polymer jet. After evaporation of the solvent and solidification of the polymer fiber, VK3/PVA-co-PE nanofibrous membranes were deposited on a wax paper-covered roller at a 15-cm tip-to-collector distance and then dried in vacuum at 40 C. for 1 hour to remove any residual solvent.
[0173] To evaluate photoactivity of the prepared photoactive nanofibrous membrane, N,N-Dimethyl-4-nitrosoaniline (p-NDA), a hydroxyl radical scavenger, was used to test the hydroxyl radical (OH., one type of ROS) produced during photoreduction process as discussed in Kraljid, I., & Trumbore, C. N. (1965). p-Nitrosodimethylaniline as an OH Radical Scavenger in Radiation Chemistry 1. Journal of the American Chemical Society, 87(12), 2547-2550. The mechanism of p-NDA to scavenge hydroxyl radical is depicted in
[0174] 10 mg of the prepared membrane was placed into 10 mL of the 510.sup.5 mol-L.sup.1 p-NDA solution and was subjected to a UVA-irradiation/dark recycle with 30-min interval alternation test. The distance between the light source and sample was 16 cm. The light intensity in the crosslinker was 6.5 mW/cm.sup.2. The amount of p-NDA left in the solution was measured quantitatively according to the standard curve after each 30 min test duration. The p-NDA consumption was transferred to hydroxyl radical production according to stoichiometry ratio mentioned above. Then the production of hydroxyl radicals was plot in graph as a function of irradiation or dark duration time. The p-NDA decomposition result is depicted in
[0175] Based on the result, the generation of OH. was mainly observed during UVA irradiation and paused during dark periods, which proves that ROS generation activity of the prepared VK3/PVA-co-PE nanofibrous membrane is triggered by light irradiation. To evaluate the OH. generation ability of the prepared nanofibrous membrane, 10 mg of the prepared membrane was placed into 10 mL of the 510.sup.5 mol-L.sup.1 p-NDA solution and placed under a UVA-irradiation for different time duration, the OH. generation efficiency of the prepared membrane can be obtained. The result is shown in
[0176] The prepared VK3/PVA-co-PE nanofibrous membrane exhibited high OH* generation capacity of 1190 g g.sup.1 h.sup.1, which was several times higher than those of other light-driven photoactive materials, which shows the robust photoactivity of the prepared nanofibrous membrane and reveals its potential in antimicrobial related applications. See Zhuo, J. (2016). Antimicrobial textiles. Woodhead Publishing.
[0177] Although the foregoing invention has been described in some detail by way of illustration and example for purposes of clarity of understanding, one of skill in the art will appreciate that certain changes and modifications may be practiced within the scope of the appended claims. In addition, each reference provided herein is incorporated by reference in its entirety to the same extent as if each reference was individually incorporated by reference. Where a conflict exists between the instant application and a reference provided herein, the instant application shall dominate.